| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 104 |
| 1 | IPILIMUMAB | 45 |
| 2 | DABRAFENIB | 8 |
| 3 | TRAMETINIB | 8 |
| 4 | PREDNISOLONE | 7 |
| 5 | PREDNISOLONE ORAL | 7 |
| 6 | PREDNISOLONE ORAL SOLUTION | 7 |
| 7 | FAMOTIDINE | 5 |
| 8 | ENFORTUMAB VEDOTIN | 4 |
| 9 | AMPICILLIN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MENTHOL, METHYL SALICYLATE | 1 | 0.0017 |
| 1 | DIFLUPREDNATE OPHTHALMIC | 1 | 0.0011 |
| 2 | NIVOLUMAB | 104 | 0.0011 |
| 3 | IPILIMUMAB | 45 | 0.0010 |
| 4 | STREPTOMYCIN | 1 | 0.0009 |
| 5 | TALIMOGENE LAHERPAREPVEC | 1 | 0.0006 |
| 6 | ENFORTUMAB VEDOTIN | 4 | 0.0005 |
| 7 | ZANAMIVIR | 1 | 0.0004 |
| 8 | DABRAFENIB | 8 | 0.0004 |
| 9 | BINIMETINIB | 3 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 104 | 0.0011 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 45 | 0.0009 |
| 2 | Neuraminidase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Chloride Channel Activator [EPC] | 2 | 0.0002 |
| 4 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 6 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |
| 7 | Bile Acid [EPC] | 1 | 0.0000 |
| 8 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Antimycobacterial [EPC] | 1 | 0.0000 |